| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Between Public Opinion and Public Policy: Human Embryonic Stem-Cell Research and Path-Dependency
|
Latham, Stephen R.
|
|
2009
|
37 |
4 |
p. 800-806
|
article
|
| 2 |
Combining Instrumental and Contextual Approaches: Nanotechnology and Sustainable Development
|
Liao, Nina
|
|
2009
|
37 |
4 |
p. 781-789
|
article
|
| 3 |
Commentary: Emerging Technologies Oversight: Research, Regulation, and Commercialization
|
Johnson, Robbin
|
|
2009
|
37 |
4 |
p. 587-593
|
article
|
| 4 |
Commentary: Evaluating Oversight of Human Drugs and Medical Devices
|
Foote, Susan Bartlett
|
|
2009
|
37 |
4 |
p. 629-632
|
article
|
| 5 |
Commentary: Is it Possible to Determine the Extent to Which Informational Asymmetries and Prejudice Bias Responses?
|
Hurley, Terrance
|
|
2009
|
37 |
4 |
p. 594-597
|
article
|
| 6 |
Commentary: Oversight of Engineered Nanomaterials in the Workplace
|
Maynard, Andrew D.
|
|
2009
|
37 |
4 |
p. 651-658
|
article
|
| 7 |
Commentary: Public Outreach by the FDA: Evaluating Oversight of Human Drugs and Medical Devices
|
Frankel, Mark S.
|
|
2009
|
37 |
4 |
p. 625-628
|
article
|
| 8 |
Commentary: Who's Afraid of the RAC? Lessons from the Oversight of Controversial Science
|
Kahn, Jeffrey P.
|
|
2009
|
37 |
4 |
p. 685-687
|
article
|
| 9 |
Comparative Health Law and Policy: What, if Anything, Can We Learn from other Countries?
|
Hoffmann, Diane
|
|
2009
|
37 |
4 |
p. 790-791
|
article
|
| 10 |
Currents in Contemporary Ethics
|
Harrell, Heather
|
|
2009
|
37 |
4 |
p. 846-851
|
article
|
| 11 |
Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences
|
Paradise, Jordan
|
|
2009
|
37 |
4 |
p. 688-705
|
article
|
| 12 |
Ethical and Legal Analyses of Policy Prohibiting Tobacco Smoking in Enclosed Public Spaces
|
Oriola, Taiwo A.
|
|
2009
|
37 |
4 |
p. 828-840
|
article
|
| 13 |
Evaluating Oversight of Human Drugs and Medical Devices: A Case Study of the FDA and Implications for Nanobiotechnology
|
Paradise, Jordan
|
|
2009
|
37 |
4 |
p. 598-624
|
article
|
| 14 |
Evaluating Oversight Systems for Emerging Technologies: A Case Study of Genetically Engineered Organisms
|
Kuzma, Jennifer
|
|
2009
|
37 |
4 |
p. 546-586
|
article
|
| 15 |
Gene Therapy Oversight: Lessons for Nanobiotechnology
|
Wolf, Susan M.
|
|
2009
|
37 |
4 |
p. 659-684
|
article
|
| 16 |
Governance of Nanotechnology and Nanomaterials: Principles, Regulation, and Renegotiating the Social Contract
|
Kimbrell, George A.
|
|
2009
|
37 |
4 |
p. 706-723
|
article
|
| 17 |
Opioid Contracts and Random Drug Testing for People with Chronic Pain — Think Twice
|
Collen, Mark
|
|
2009
|
37 |
4 |
p. 841-845
|
article
|
| 18 |
Problem Formulation and Option Assessment (PFOA) Linking Governance and Environmental Risk Assessment for Technologies: A Methodology for Problem Analysis of Nanotechnologies and Genetically Engineered Organisms
|
Nelson, Kristen C.
|
|
2009
|
37 |
4 |
p. 732-748
|
article
|
| 19 |
Realization of the International Human Right to Health in an Economically Integrated North America
|
Kinney, Eleanor D.
|
|
2009
|
37 |
4 |
p. 807-818
|
article
|
| 20 |
Review of the OSHA Framework for Oversight of Occupational Environments
|
Choi, Jae-Young
|
|
2009
|
37 |
4 |
p. 633-650
|
article
|
| 21 |
Reviews in Health Law
|
Coughlin, Christine Nero
|
|
2009
|
37 |
4 |
p. 857-859
|
article
|
| 22 |
Risk Communication for Nanobiotechnology: To Whom, about What, and Why?
|
Priest, Susanna Hornig
|
|
2009
|
37 |
4 |
p. 759-769
|
article
|
| 23 |
Science, Ethics, and the “Problems” of Governing Nanotechnologies
|
Hogle, Linda F.
|
|
2009
|
37 |
4 |
p. 749-758
|
article
|
| 24 |
Teaching Health Law
|
Singer, Lawrence E.
|
|
2009
|
37 |
4 |
p. 852-856
|
article
|
| 25 |
The Challenge of Developing Oversight Approaches to Nanobiotechnology
|
Paradise, Jordan
|
|
2009
|
37 |
4 |
p. 543-545
|
article
|
| 26 |
Tobacco Industry Use of Corporate Social Responsibility Tactics as a Sword and a Shield on Secondhand Smoke Issues
|
Friedman, Lissy C.
|
|
2009
|
37 |
4 |
p. 819-827
|
article
|
| 27 |
Using Expert Elicitation to Prioritize Resource Allocation for Risk Identification for Nanosilver
|
Fauss, Emma
|
|
2009
|
37 |
4 |
p. 770-780
|
article
|
| 28 |
What Does the History of Technology Regulation Teach Us about Nano Oversight?
|
Marchant, Gary E.
|
|
2009
|
37 |
4 |
p. 724-731
|
article
|
| 29 |
Why Patients Sue Doctors: The Japanese Experience
|
Feldman, Eric A.
|
|
2009
|
37 |
4 |
p. 792-799
|
article
|
Journal description